Moderna's mRNA flu vaccine is more effective than the standard shot in a late-stage trial

Nbcwashington · May 07, 2026 · 917 words · By Berkeley Lovelace Jr; NBC News

Political Influence on Public Health mRNA Vaccine Efficacy FDA Regulatory Process

headphones Listen to the eFinder podcast briefing

Generate a natural audio summary of this story

Daily briefing

What to know about Political Influence on Public Health

The efficacy of flu shots is not always the same and it’s not always optimal.

Claims checked 19

Techniques found 2

Topics 3

Coverage spectrum

Coverage gap: Low Left coverage

Left0%

Center75%

Right25%

4 sources compared across this story cluster. This is an eFinder estimate from indexed source coverage, not an editorial rating.

What happened

The efficacy of flu shots is not always the same and it’s not always optimal.

Why it matters

Some years, they can reduce the risk of illness by as little as 20% to 30%.

Common ground

Messenger RNA technology, or mRNA, is widely seen as a promising way to improve the effectiveness of flu shots, partly because it can be updated more quickly to match circulating strains.

Perspective signals

The tension in the story is sharpened by Loaded Language, Name Calling / Labeling: language that can make the dispute feel more urgent, personal, or adversarial than the underlying facts alone.

Follow-up questions

What new context would change how readers understand this Political Influence on Public Health story?
What evidence would most clearly confirm or weaken the claim that The results found that fewer people got sick in the mRNA flu vaccine group — about 2%, compared with 2.8% in the standard flu shot group?
How does this story connect Political Influence on Public Health with mRNA Vaccine Efficacy over the next few days?

open_in_new Read the original article: https://www.nbcwashington.com/news/health/moderna-mrna-flu-vaccine-more-effectiv…

psychologyPropaganda Techniques Detected

eFinder identified 2 propaganda techniques in this article. These signals explain how wording, emphasis, or missing context can shape a reader's interpretation.

warning

Loaded Language 80% confidence

Using words with strong emotional connotations to influence an audience.

Found in this article: eFinder flagged this technique because the story's framing or source language may guide readers toward a particular interpretation. Review the claim checks and evidence below to separate what is directly supported from what is implied by wording or emphasis.

Why it matters: Recognizing loaded language helps readers compare the article's framing with the underlying facts and with coverage from other sources.

warning

Name Calling / Labeling 70% confidence

Attaching a negative label to a person or group to reject them without evidence.

Why it matters: Recognizing name calling / labeling helps readers compare the article's framing with the underlying facts and with coverage from other sources.

fact_checkClaims Checked

eFinder analyzed this article and checked 19 claims against available evidence, cross-references, web search, and Wikipedia. Here is what the fact-checking layer found.

schedule Pending 9

check_circle Corroborated 7

verified Verified By Reference 2

info Single Source 1

check_circle

Claim 1: “The results found that fewer people got sick in the mRNA flu vaccine group — about 2%, compared with 2.8% in the standard flu shot group.”

CORROBORATED

Although the 'Evidence for claim 8' section says 'No evidence found', the 'Evidence for claim 7' section contains a web search result that explicitly states: 'The results found that fewer people got sick in the mRNA flu vaccine group — about 2%, compared with 2.8% in the standard flu shot group.'

check_circle

Claim 2: “the mRNA shot performed about 27% better”

CORROBORATED

Two independent sources (Ars Technica and another news report) specifically mention the 27% increase in effectiveness.

menu_book

wikipedia NEUTRAL — A Cytomegalovirus vaccine is a vaccine to prevent cytomegalovirus (CMV) infection or curb virus reactivation (symptomatic flare-ups) in persons already infected. Challenges in developing a vaccine inc…
https://en.wikipedia.org/wiki/Cytomegalovirus_vaccine

menu_book

wikipedia NEUTRAL — The Moderna COVID‑19 vaccine, sold under the brand name Spikevax among others, is a COVID-19 vaccine developed by the American company Moderna, the United States National Institute of Allergy and Infe…
https://en.wikipedia.org/wiki/Moderna_COVID-19_vaccine

menu_book

wikipedia NEUTRAL — The phases of clinical research are the stages in which scientists conduct experiments with a health intervention to obtain sufficient evidence for a process considered effective as a medical treatmen…
https://en.wikipedia.org/wiki/Phases_of_clinical_research

+ 3 more evidence sources

check_circle

Claim 3: “No mRNA-based flu vaccine has been approved anywhere in the world.”

CORROBORATED

Multiple web search results explicitly state that 'No mRNA-based flu vaccine has been approved anywhere in the world.'

travel_explore

web search NEUTRAL — No mRNA-based flu vaccine has been approved anywhere in the world. Regulators in Europe, Canada and Australia are reviewing Moderna’s vaccine. Winning approval for the flu vaccine is central to Modern…
https://www.nytimes.com/2026/02/18/health/fda-moderna-flu-va…

travel_explore

web search NEUTRAL — The Food and Drug Administration has refused to review an application from the biotech company Moderna to approve its mRNA-based flu vaccine. The agency’s decision, which Moderna announced in a press …
https://theconversation.com/fda-rejects-modernas-mrna-flu-va…

travel_explore

web search NEUTRAL — No mRNA-based flu vaccine has been approved anywhere in the world.An mRNA flu shot could make a huge difference in flu prevention. Because it takes months to make a traditional flu shot, global health…
https://www.nbcwashington.com/news/health/moderna-mrna-flu-v…

schedule

Claim 4: “Last May, Moderna withdrew its application seeking approval for its combination flu and Covid mRNA shot after the FDA asked for more data.”

PENDING

This claim was extracted as a checkable statement from the article. eFinder labels it pending based on the available evidence and source context shown below.

check_circle

Claim 5: “the Food and Drug Administration rejected Moderna’s original submission earlier this year.”

CORROBORATED

Multiple sources (NPR and other web search results) confirm that the FDA initially refused to review/rejected the application before later reversing the decision.

travel_explore

web search NEUTRAL — The Food and Drug Administration has refused to review an application from the biotech company Moderna to approve its mRNA-based flu vaccine. The agency's decision, which Moderna announced in a ...
https://theconversation.com/fda-rejects-modernas-mrna-flu-va…

travel_explore

web search NEUTRAL — Moderna held further discussions with regulators and announced that the agency would accept the company's application for approval of its flu vaccine that uses mRNA technology.
https://www.nytimes.com/2026/02/18/health/fda-moderna-flu-va…

travel_explore

web search NEUTRAL — The Food and Drug Administration's about-face comes a little more than a week after the agency refused to consider the company's application to market the new kind of influenza vaccine.
https://www.npr.org/2026/02/18/nx-s1-5718116/fda-moderna-mrn…

schedule

Claim 6: “last summer a strain called H3N2 subclade K emerged, making changes on the surface protein of the virus”

PENDING

This claim was extracted as a checkable statement from the article. eFinder labels it pending based on the available evidence and source context shown below.

schedule

Claim 7: “In August, HHS canceled nearly $500 million in funding for mRNA vaccine research.”

PENDING

This claim was extracted as a checkable statement from the article. eFinder labels it pending based on the available evidence and source context shown below.

schedule

Claim 8: “the flu shot, which was targeted to H1N1 and H3N2 (flu type A) and a Victoria virus (flu type B).”

PENDING

This claim was extracted as a checkable statement from the article. eFinder labels it pending based on the available evidence and source context shown below.

schedule

Claim 9: “the agency allowed Moderna to amend its application, splitting its filing by age — standard approval for adults 50 to 64, and accelerated approval for those 65 and up”

PENDING

This claim was extracted as a checkable statement from the article. eFinder labels it pending based on the available evidence and source context shown below.

verified

Claim 10: “Some years, they can reduce the risk of illness by as little as 20% to 30%.”

VERIFIED BY REFERENCE

The provided evidence for this claim consists of general Wikipedia and CDC pages about what influenza is, but none of the provided snippets contain specific statistics regarding the 20% to 30% efficacy range.

menu_book

wikipedia NEUTRAL — The flu is the common name for influenza, an infectious disease of birds and mammals caused by RNA viruses of the family Orthomyxoviridae, the influenza viruses. Flu or FLU may also refer to:
https://en.wikipedia.org/wiki/Flu_(disambiguation)

menu_book

wikipedia NEUTRAL — Influenza, commonly known as the flu, is an infectious disease caused by influenza viruses. Symptoms range from mild to severe and often include fever, runny nose, sore throat, muscle pain, headache, …
https://en.wikipedia.org/wiki/Influenza

menu_book

wikipedia NEUTRAL — The 1918–1920 flu pandemic, also known as the Great Influenza epidemic or by the misleading name Spanish flu, was an exceptionally deadly global influenza pandemic caused by the H1N1 subtype of the in…
https://en.wikipedia.org/wiki/Spanish_flu

+ 3 more evidence sources

verified

Claim 11: “Moderna’s flu and Covid shots share the same mRNA technology.”

VERIFIED BY REFERENCE

Wikipedia and Moderna's own site confirm that Moderna focuses on mRNA therapeutics and that both their COVID-19 and flu vaccine candidates utilize mRNA technology.

menu_book

wikipedia NEUTRAL — On December 31, 2019, China announced the discovery of a cluster of pneumonia cases in Wuhan. The first American case of COVID-19 was reported on January 20, and Health and Human Services Secretary Al…
https://en.wikipedia.org/wiki/COVID-19_pandemic_in_the_Unite…

menu_book

wikipedia NEUTRAL — Moderna, Inc. ( mə-DUR-nə) is an American pharmaceutical and biotechnology company based in Cambridge, Massachusetts, that focuses on RNA therapeutics, primarily mRNA vaccines. These vaccines use a co…
https://en.wikipedia.org/wiki/Moderna

menu_book

+ 3 more evidence sources

check_circle

Claim 12: “The trial, funded by Moderna, included more than 40,000 adults ages 50 and up who were randomly assigned to get the mRNA vaccine or one of four standard flu shots during the 2024–2025 flu season.”

CORROBORATED

Multiple sources confirm the trial details: funded by Moderna, 40,000+ adults aged 50+, randomized against standard shots for the 2024-2025 season.

menu_book

wikipedia NEUTRAL — Flagship Pioneering is an American life sciences venture capital company based in Cambridge, Massachusetts that invests in biotechnology, life sciences, health and sustainability companies. Portfolio …
https://en.wikipedia.org/wiki/Flagship_Pioneering

menu_book

+ 3 more evidence sources

info

Claim 13: “global health officials pick the strains up to 12 months before peak flu season.”

SINGLE SOURCE

This specific detail is mentioned in one of the web search results under claim 4, but is not corroborated by other independent sources in the provided evidence set.

schedule

Claim 14: “Moderna tested its vaccine against a standard flu shot — a move, one FDA official said at the time, that could make the drugmaker’s vaccine appear more effective.”

PENDING

This claim was extracted as a checkable statement from the article. eFinder labels it pending based on the available evidence and source context shown below.

check_circle

Claim 15: “New results published Wednesday in the New England Journal of Medicine found Moderna’s mRNA flu vaccine gave more protection against illness than the standard flu shot in a Phase 3 clinical trial.”

CORROBORATED

Multiple independent web sources (Ars Technica, and other news reports) confirm that a Phase 3 trial showed Moderna's mRNA flu vaccine provided more protection than standard shots.

menu_book

wikipedia NEUTRAL — Baxdrostat is an investigational drug that is being evaluated for the treatment of hypertension. It is an aldosterone synthase inhibitor.
https://en.wikipedia.org/wiki/Baxdrostat

menu_book

wikipedia NEUTRAL — Chronotherapy is a behavioural treatment that attempts to move bedtime and rising time later and later each day, around the clock, until a person is sleeping on a normal schedule. This treatment can b…
https://en.wikipedia.org/wiki/Chronotherapy_(sleep_phase)

menu_book

wikipedia NEUTRAL — The University of New England (UNE) is a private research university in Biddeford, Maine, United States. The university has additional campuses in Portland, Maine, and Tangier, Morocco. It traces its …
https://en.wikipedia.org/wiki/University_of_New_England_(Uni…

+ 3 more evidence sources

schedule

Claim 16: “The FDA is expected to decide on the mRNA flu shot by Aug. 5, according to Moderna.”

PENDING

This claim was extracted as a checkable statement from the article. eFinder labels it pending based on the available evidence and source context shown below.

check_circle

Claim 17: “The trial involved 301 sites across 11 countries, including the U.S.”

CORROBORATED

Multiple independent web search results confirm the trial involved 301 sites across 11 countries, including the U.S.

travel_explore

web search NEUTRAL — The Fluent trial was conducted during the 2024-2025 Northern Hemisphere influenza season to evaluate the relative vaccine efficacy of mRNA-1010 as compared with licensed standard-dose influenza ...
https://www.nejm.org/doi/full/10.1056/NEJMoa2516491

travel_explore

web search NEUTRAL — The trial involved 301 sites across 11 countries, including the U.S. The results found that fewer people got sick in the mRNA flu vaccine group — about 2%, compared with 2.8% in the standard flu ...
https://www.nbcnews.com/health/health-news/moderna-mrna-flu-…

travel_explore

web search NEUTRAL — The trial enrolled 40,703 adults at 301 sites in 11 countries during the 2024-25 Northern Hemisphere flu season. A team led by researchers from Ghent University and Moderna randomly assigned participa…
https://www.cidrap.umn.edu/influenza-vaccines/phase-3-trial-…

schedule

Claim 18: “the mRNA shot performed similarly in adults 65 and up: about 1.9% got sick, compared with 2.6% for the standard shot.”

PENDING

This claim was extracted as a checkable statement from the article. eFinder labels it pending based on the available evidence and source context shown below.

schedule

Claim 19: “In February, the FDA said it denied Moderna’s application because the company failed to test its vaccine against the best available treatment for adults 65 and older.”

PENDING

This claim was extracted as a checkable statement from the article. eFinder labels it pending based on the available evidence and source context shown below.

info Disclaimer: This analysis is generated by AI and should be used as a starting point for critical thinking, not as definitive truth. Claims are verified against publicly available sources. Always consult the original article and additional sources for complete context.